Wall Street analysts forecast that Bristol Myers Squibb (BMY) will report quarterly earnings of $1.50 per share in its upcoming release, pointing to a year-over-year decline of 25%. It is anticipated that revenues will amount to $11.3 billion, exhibiting an increase of 3% compared to the year-ago quarter. The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraise ...